Centric Wealth Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
DAM
F
Centric Wealth Management's NVO Position: Q1 2026 in Review
Centric Wealth Management sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 6,887 shares — an estimated $406K sold.
Centric Wealth Management first reported a position in NVO in Q2 2021 and held it in 19 quarters. The position peaked at $829K in Q2 2024. 1,277 funds tracked by Wall St. Rank hold NVO as of Q1 2026.
- Centric Wealth Management reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
- Centric Wealth Management sold 6,887 Novo Nordisk shares in Q1 2026, an estimated $406K.
- Centric Wealth Management first reported a position in Novo Nordisk in Q2 2021 and held it in 19 quarters.
- Centric Wealth Management's Novo Nordisk position peaked at $829K in Q2 2024.
- 1,277 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.
Based on Centric Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.